Ganesha, I dont have a single link to show that Dr.

New Post Public Reply Private Reply Replies (1) Message Board
havasu78 Ganesha #61323
712
Ganesha, I dont have a single link to show that Dr. Seethamraju bulldozed the FDA into approving LL despite an absence of clinical studies and also despite the FDA scientists' belief that leronlimab had no application to leronlimab.

i don't think that there exists a single document or interview which relates all of the details.

At least twicein interviews or conference calls, Pourhassan has explained that Cytodyn requested to use leronlimab on covid patients way back in March and the FDA said "No, you have to do some preclinical studies."

So the FDA categorically denied Cytodyn's request to try leronlimab on covid.

Without a doubt, there are no preclinical leronlimab studies for covid. They do not exist. And that is the basis for the FDA's denial to try LL in covid.

Enter Dr. Seethamraju. At least three times in conference calls or interview, Pourhassan explained that Dr. Seethamraju solicited the FDA to use LL on two of his terminal patients. Dr. Seethamraju's FDA solicitation occurred after the FDA had already declined Cytodyn's request to try LL in covid.

Somehow or other, Dr. Seethamraju prevailed in his solicitation of the FDA, and the FDA agreed to let Dr. Seethamraju try LL on two terminal covid patients.

A key question that has never been answered, maybe even never asked, is:

Why was Dr. Seethamraju able to prevail at the FDA where Cytodyn could not? Of course Dr. Seethamraju was watching his patients die, so there is that.

When the first two patients responded postively to lernlimab, the EIND floodgates opened for LL.

This story, told several times by Pourhassan, is why Pourhassan calls Seethamraju the "hero doctor".

Also told in the story at least twice by Pourhassan is the part that the FDA did not believe leronlimab would do anything for covid. There was no mechanism of action.

Its not surprising that the FDA scientists believed LL had no application to covid because at that time, Patterson's preprint was obviously not published. Patterson and others must have had the idea, but it was just an idea and a pretty new one at that. RANTES signalling as a contribution to covid deaths was not widely known, let alone believed, by many people.

Perhaps Dr. Bruce Patterson played some sort of key role supporting Dr. Seethamraju's solicitaion of the FDA, but the way Seethamraju is going it looks like he may not need help from anyone

A google search for " seethamraju 'hero doctor' " gets a few hits so you might be able to start there.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Thermoplastic Polyimide: A $0.86 Billion Market by 2032

Updated Category News Views 0

It's not often you get hyped about a compound with a name like 'thermoplastic polyimide,' but hold your horses—this isn't just any chemical. If you're watching markets with a sharp eye, you’ll see this thing estimated at $0.56 billion in 2026, gunning for a hefty $0.86 billion by 2032. We're talking about a solid 7.4% CAGR ride here folks, according to new data from...

Continue Reading
Moonlock: Award-Winning Design Elevates Cybersecurity's Importance

Updated Category News Views 2

Design Excellence Meets Cybersecurity There's a new sheriff in town when it comes to cybersecurity design, and its name is Moonlock. MacPaw's antivirus and protection app pulled off a coup by bagging the 2026 Red Dot Award in the Interface & User Experience Design category. It's a big deal in the cybersecurity realm, where functionality often overshadows finesse. But...

Continue Reading
CIMAMotor 2026: A Massive Gathering in Motorcycle Mecca

Updated Category News Views 2

Unprecedented Scale at CIMAMotor 2026 Come September, the 24th China International Motorcycle Trade Exhibition, also known as CIMAMotor 2026, is set to roar through the corridors of the Chongqing International Expo Center. With more than 1,000 exhibitors and over 3,000 vehicles on display, it’s clear this isn’t just another trade show—this is a full-blown spectacle...

Continue Reading
Europe's Largest Carbon Capture Facility Launches

Updated Category News Views 1

A New Chapter in Industrial Decarbonization Today's not just your average ribbon-cutting ceremony; it's a landmark turn in our journey toward a cleaner Europe. Yara's Sluiskil plant in the Netherlands just fired up Europe's biggest carbon capture facility, marking a crucial pivot point in industrial decarbonization. We're talking about capturing a staggering 800,000 tons...

Continue Reading
Montana Dreams: Faith in New Beginnings

Updated Category News Views 3

Kickstart into a Faith-Fueled Tale Out of Lillington, N.C. comes a novel that isn't just pages of printed text, but almost a life lesson wrapped in fiction. Lee Jennings serves up "Home in Montana," a Christian romance mystery that throws a kaleidoscope of emotions onto the reader's lap, whether they're relaxed in a recliner or flipping through it on their lunch break....

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 2

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
GBC 2026 Wraps Up: Korea Eyes Bio Industry Leadership

Updated Category News Views 2

GBC 2026: Korea's Giant Leap in Bio Innovation Well, there wasn't a dull moment at the 'Global Bio Conference 2026' in Seoul. Picture a melting pot where 5,600 participants from 19 countries converged to chat about the latest and greatest in biopharma innovation and regulatory strategies. That's not a setup you see every day, mind you. This event packed the room with...

Continue Reading
Insurance 101: Know Your Limits and Deductibles

Updated Category News Views 0

It might not exactly be cocktail party fodder, but boy, skipping on understanding your homeowners insurance is a shortcut straight to financial hell. You’re living in St. Albans, WV, in a home that’s probably your biggest investment. Let’s talk about this before you find yourself in a mess you should've seen coming. Why Coverage Limits Matter a Whole Lot Listen up,...

Continue Reading
Tech Breakthroughs in Cancer and Space Energy Aired

Updated Category News Views 1

Science and Technology at the Forefront Saturday nights usually have folks kicking back with some reality shows or maybe cheering on their favorite sports team. But this September 12, savvy viewers have a chance to dive deep into the guts of cutting-edge science and tech on Bloomberg Television. We're talking about 'Advancements with Ted Danson'—where science isn’t...

Continue Reading
AI and Workforce Transformation: Zellis Connect 2026

Updated Category News Views 2

AI Transformation: Hard Reality or Strategic Opportunity? The future of work. That’s what everyone’s buzzing about lately, isn’t it? AI poised to shake every nook and cranny. You're either riding the wave or getting crushed by it. It’s no longer some distant prospect—the challenge is right here, now. Come September 23, Zellis Connect 2026 is plunging headfirst...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Worker Priorities Across Different Industries

Updated Category News Views 239

Grant Thornton Survey Reveals Key Worker Priorities Grant Thornton, a prominent American firm known for its comprehensive audit, assurance, tax, and advisory services, has unveiled compelling industry-specific insights through its latest survey. The State of Work in America survey highlights critical trends shaping employee attitudes, desires, and worries across various...

Continue Reading
Exploring the Coagulation Market and its Future Growth

Updated Category News Views 196

Overview of the Coagulation Market Dynamics The coagulation market is gaining remarkable traction, with expectations to grow significantly over the coming years. Reports indicate that this market is forecasted to expand from US$ 6.29 billion in 2022 to a substantial US$ 10.85 billion by 2030, showcasing a compounded annual growth rate (CAGR) of 7.0%. This growth is...

Continue Reading
WinVest Acquisition Corp. Changes Special Meeting Date for Stockholders

Updated Category News Views 138

WinVest Acquisition Corp. Special Meeting Postponed The announcement coming from WinVest Acquisition Corp. is significant, marking a delay for its special meeting initially set for stockholders. Although the date was intended for a strategic discussion about the company’s future, it has been shifted to a date that remains to be determined. Implications of the...

Continue Reading
Radware Secures Top Spot in KuppingerCole Web Security Report

Updated Category News Views 212

Radware Achieves Leadership Recognition in Cybersecurity Radware, a premier name in cyber security and application delivery solutions, has made headlines by being named an Overall Leader in KuppingerCole’s 2025 Leadership Compass Report focusing on Web Application and API Protection. This exceptional acknowledgment highlights Radware’s stellar performance and...

Continue Reading
CITGO Lemont Refinery Successfully Supports Local Community

Updated Category News Views 279

CITGO Lemont Refinery's Remarkable Community Impact The CITGO Lemont Refinery has made a notable contribution to its local community, recently completing its annual employee giving campaign for the United Way. This initiative saw incredible participation, with over 150 CITGO employees coming together to raise more than $190,000. The generosity shown during this campaign...

Continue Reading